2276. Immunogenicity of Takeda’s Bivalent Virus-Like Particle (VLP) Norovirus Vaccine (NoV) Candidate in Children From 6 Months up to 4 Years of Age

por Masuda, Taisei, Lefevre, Inge, Mendelman, Paul, Sherwood, Jim, Bizjajeva, Svetlana, Borkowski, Astrid
Publicado 2018

Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial

por Espinoza, Felix, Tregnaghi, Miguel, Gentile, Angela, Abarca, Katia, Casellas, Javier, Collard, Alix, Lefevre, Inge, Jacquet, Jeanne-Marie
Publicado 2010

Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, contro...

por Tricou, Vianney, Essink, Brandon, Ervin, John E., Turner, Mark, Escudero, Ian, Rauscher, Martina, Brose, Manja, Lefevre, Inge, Borkowski, Astrid, Wallace, Derek
Publicado 2023